Latest Breaking News On - Phase 2b fg001 ct 001 trial eudract 2020 003089 38 - Page 1 : comparemela.com

The use of the optical imaging agent FG001 led to the detection of additional cancer by optical guidance in patients with high-grade glioma, meeting the primary end point of the phase 2b FG001-CT-001 trial.

Andreas kjaerJane skjDepartment of neurosurgery at rigshospitaletHigh grade gliomaPhase 2b fg001 ct 001 trial eudract 2020 003089 38